CA1339221C - Polyhydroxybenzoic acid derivatives - Google Patents
Polyhydroxybenzoic acid derivativesInfo
- Publication number
- CA1339221C CA1339221C CA000454910A CA454910A CA1339221C CA 1339221 C CA1339221 C CA 1339221C CA 000454910 A CA000454910 A CA 000454910A CA 454910 A CA454910 A CA 454910A CA 1339221 C CA1339221 C CA 1339221C
- Authority
- CA
- Canada
- Prior art keywords
- noh
- compound
- compound according
- ethyl
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002253 acid Substances 0.000 title claims abstract description 11
- 150000001875 compounds Chemical class 0.000 claims abstract description 83
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 22
- 150000003254 radicals Chemical class 0.000 claims abstract description 11
- 150000003839 salts Chemical class 0.000 claims abstract description 11
- 238000011282 treatment Methods 0.000 claims abstract description 6
- 201000010099 disease Diseases 0.000 claims abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 4
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 3
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims abstract 12
- -1 2,3,4-trihydroxybenzamidate isopropyl 3,5-dihydroxybenzimidate Chemical compound 0.000 claims description 36
- 238000000034 method Methods 0.000 claims description 29
- 238000002360 preparation method Methods 0.000 claims description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 17
- 150000002825 nitriles Chemical class 0.000 claims description 15
- 238000006243 chemical reaction Methods 0.000 claims description 14
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 14
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 13
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 claims description 12
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 12
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 12
- 102000000505 Ribonucleotide Reductases Human genes 0.000 claims description 11
- 108010041388 Ribonucleotide Reductases Proteins 0.000 claims description 11
- 230000008569 process Effects 0.000 claims description 11
- JOAASNKBYBFGDN-UHFFFAOYSA-N chembl1214554 Chemical compound ON=C(N)C1=CC=C(O)C(O)=C1 JOAASNKBYBFGDN-UHFFFAOYSA-N 0.000 claims description 10
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 10
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 claims description 9
- OHCQBZQVFIBAIV-UHFFFAOYSA-N 3,4,5-trihydroxybenzonitrile Chemical compound OC1=CC(C#N)=CC(O)=C1O OHCQBZQVFIBAIV-UHFFFAOYSA-N 0.000 claims description 8
- 239000007864 aqueous solution Substances 0.000 claims description 8
- MSLJYSGFUMYUDX-UHFFFAOYSA-N Trimidox Chemical compound ON=C(N)C1=CC(O)=C(O)C(O)=C1 MSLJYSGFUMYUDX-UHFFFAOYSA-N 0.000 claims description 6
- GPXIMVVEQNCDGW-UHFFFAOYSA-N 2,3,4-trihydroxybenzonitrile Chemical compound OC1=CC=C(C#N)C(O)=C1O GPXIMVVEQNCDGW-UHFFFAOYSA-N 0.000 claims description 5
- NUWHYWYSMAPBHK-UHFFFAOYSA-N 3,4-dihydroxybenzonitrile Chemical compound OC1=CC=C(C#N)C=C1O NUWHYWYSMAPBHK-UHFFFAOYSA-N 0.000 claims description 5
- YPDCARQCUJAWLA-UHFFFAOYSA-N N',2,3,4-tetrahydroxybenzenecarboximidamide Chemical compound ON=C(N)C1=CC=C(O)C(O)=C1O YPDCARQCUJAWLA-UHFFFAOYSA-N 0.000 claims description 5
- MXOQNVMDKHLYCZ-UHFFFAOYSA-N benzamidoxime Chemical compound ON=C(N)C1=CC=CC=C1 MXOQNVMDKHLYCZ-UHFFFAOYSA-N 0.000 claims description 5
- RBQIPEJXQPQFJX-UHFFFAOYSA-N 3,4,5-trihydroxybenzamide Chemical compound NC(=O)C1=CC(O)=C(O)C(O)=C1 RBQIPEJXQPQFJX-UHFFFAOYSA-N 0.000 claims description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 4
- FVYBAJYRRIYNBN-UHFFFAOYSA-N n'-hydroxy-2-phenylethanimidamide Chemical compound ON=C(N)CC1=CC=CC=C1 FVYBAJYRRIYNBN-UHFFFAOYSA-N 0.000 claims description 4
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 4
- JTNCEQNHURODLX-UHFFFAOYSA-N 2-phenylethanimidamide Chemical compound NC(=N)CC1=CC=CC=C1 JTNCEQNHURODLX-UHFFFAOYSA-N 0.000 claims description 3
- 239000002841 Lewis acid Substances 0.000 claims description 3
- 229940059260 amidate Drugs 0.000 claims description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 3
- 150000007517 lewis acids Chemical class 0.000 claims description 3
- GXYVISXLFBQBKH-UHFFFAOYSA-N n',2-dihydroxy-2-phenylethanimidamide Chemical compound ON=C(N)C(O)C1=CC=CC=C1 GXYVISXLFBQBKH-UHFFFAOYSA-N 0.000 claims description 3
- WDKIHNKPXHYPDH-UHFFFAOYSA-N 2-(2,3,4,5-tetrahydroxyphenyl)acetamide Chemical compound NC(=O)CC1=CC(O)=C(O)C(O)=C1O WDKIHNKPXHYPDH-UHFFFAOYSA-N 0.000 claims description 2
- BCXCZGJJJIXPCP-UHFFFAOYSA-N 2-(2,3,4-trihydroxyphenyl)acetamide Chemical compound NC(=O)CC1=CC=C(O)C(O)=C1O BCXCZGJJJIXPCP-UHFFFAOYSA-N 0.000 claims description 2
- SMRAJKANWACYNO-UHFFFAOYSA-N 2-(2,3-dihydroxyphenyl)acetamide Chemical compound NC(=O)CC1=CC=CC(O)=C1O SMRAJKANWACYNO-UHFFFAOYSA-N 0.000 claims description 2
- UPAPCDWRDJOKLU-UHFFFAOYSA-N 2-(3,4,5-trihydroxyphenyl)acetamide Chemical compound NC(=O)CC1=CC(O)=C(O)C(O)=C1 UPAPCDWRDJOKLU-UHFFFAOYSA-N 0.000 claims description 2
- PFDFJMIGPOJBQV-UHFFFAOYSA-N 2-(3,4-dihydroxyphenyl)acetamide Chemical compound NC(=O)CC1=CC=C(O)C(O)=C1 PFDFJMIGPOJBQV-UHFFFAOYSA-N 0.000 claims description 2
- PGXUFOSNLJVHBH-UHFFFAOYSA-N 2-(3,5-dihydroxyphenyl)acetamide Chemical compound NC(=O)CC1=CC(O)=CC(O)=C1 PGXUFOSNLJVHBH-UHFFFAOYSA-N 0.000 claims description 2
- 241001465754 Metazoa Species 0.000 claims description 2
- FZKWXDBVCGROTJ-UHFFFAOYSA-N NC(=O)CC1=C(O)C=C(O)C(O)=C1O Chemical compound NC(=O)CC1=C(O)C=C(O)C(O)=C1O FZKWXDBVCGROTJ-UHFFFAOYSA-N 0.000 claims description 2
- BLSAOOFJSYAAHH-UHFFFAOYSA-N NC(=O)CC1=CC(O)=C(O)C=C1O Chemical compound NC(=O)CC1=CC(O)=C(O)C=C1O BLSAOOFJSYAAHH-UHFFFAOYSA-N 0.000 claims description 2
- 229910052783 alkali metal Inorganic materials 0.000 claims description 2
- 229910021529 ammonia Inorganic materials 0.000 claims description 2
- NPUKDXXFDDZOKR-LLVKDONJSA-N etomidate Chemical compound CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1 NPUKDXXFDDZOKR-LLVKDONJSA-N 0.000 claims description 2
- 150000002632 lipids Chemical class 0.000 claims description 2
- 230000001613 neoplastic effect Effects 0.000 claims description 2
- 230000003647 oxidation Effects 0.000 claims description 2
- 238000007254 oxidation reaction Methods 0.000 claims description 2
- 241000124008 Mammalia Species 0.000 claims 3
- 239000012736 aqueous medium Substances 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 230000002000 scavenging effect Effects 0.000 claims 2
- MJJMOAZGJRRRNX-UHFFFAOYSA-N 2,4,5-trihydroxybenzamide Chemical compound NC(=O)C1=CC(O)=C(O)C=C1O MJJMOAZGJRRRNX-UHFFFAOYSA-N 0.000 claims 1
- AFXGCWGNLJLYEZ-UHFFFAOYSA-N 2-hydroxy-2-phenylethanimidamide Chemical compound NC(=N)C(O)C1=CC=CC=C1 AFXGCWGNLJLYEZ-UHFFFAOYSA-N 0.000 claims 1
- 230000006820 DNA synthesis Effects 0.000 claims 1
- ISASSBJTOPCVOX-UHFFFAOYSA-N OC1=C(C(=N)N)C=CC(=C1O)O.OC1=C(C(=N)N)C=CC=C1O.OC=1C=C(C(=N)N)C=C(C1O)O Chemical compound OC1=C(C(=N)N)C=CC(=C1O)O.OC1=C(C(=N)N)C=CC=C1O.OC=1C=C(C(=N)N)C=C(C1O)O ISASSBJTOPCVOX-UHFFFAOYSA-N 0.000 claims 1
- HDYJRJSECHNYMJ-UHFFFAOYSA-N OC=1C=C(C(=N)N)C=C(C1)O.OC1=C(C(=N)N)C=C(C(=C1)O)O Chemical compound OC=1C=C(C(=N)N)C=C(C1)O.OC1=C(C(=N)N)C=C(C(=C1)O)O HDYJRJSECHNYMJ-UHFFFAOYSA-N 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 230000010261 cell growth Effects 0.000 claims 1
- 239000007795 chemical reaction product Substances 0.000 claims 1
- 230000001419 dependent effect Effects 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000002609 medium Substances 0.000 claims 1
- 238000007911 parenteral administration Methods 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- 230000002335 preservative effect Effects 0.000 claims 1
- 230000029812 viral genome replication Effects 0.000 claims 1
- 239000002516 radical scavenger Substances 0.000 abstract description 4
- 229940123457 Free radical scavenger Drugs 0.000 abstract description 2
- 229940127395 Ribonucleotide Reductase Inhibitors Drugs 0.000 abstract description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 33
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 31
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- 239000000243 solution Substances 0.000 description 17
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 14
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 14
- 238000004458 analytical method Methods 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 238000000354 decomposition reaction Methods 0.000 description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- 238000001704 evaporation Methods 0.000 description 9
- 230000008020 evaporation Effects 0.000 description 9
- 238000001953 recrystallisation Methods 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 241000699670 Mus sp. Species 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 239000000470 constituent Substances 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 239000011541 reaction mixture Substances 0.000 description 8
- 230000004083 survival effect Effects 0.000 description 8
- 231100000331 toxic Toxicity 0.000 description 8
- 230000002588 toxic effect Effects 0.000 description 8
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 7
- 208000032839 leukemia Diseases 0.000 description 7
- 239000011877 solvent mixture Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 6
- BZMWYVQJKXCMQK-UHFFFAOYSA-N 2,3,4,5,6-pentahydroxybenzonitrile Chemical compound OC1=C(O)C(O)=C(C#N)C(O)=C1O BZMWYVQJKXCMQK-UHFFFAOYSA-N 0.000 description 5
- FCMKUVQNNKLVHF-UHFFFAOYSA-N 2,3,4,5-tetrahydroxybenzonitrile Chemical compound OC1=CC(C#N)=C(O)C(O)=C1O FCMKUVQNNKLVHF-UHFFFAOYSA-N 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 125000000217 alkyl group Chemical group 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 230000000875 corresponding effect Effects 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 230000007760 free radical scavenging Effects 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- PGKWKZZRJYUEMR-UHFFFAOYSA-N 2-hydroxy-3,4,5-trimethoxybenzamide Chemical compound COC1=CC(C(N)=O)=C(O)C(OC)=C1OC PGKWKZZRJYUEMR-UHFFFAOYSA-N 0.000 description 4
- VSNHCAURESNICA-UHFFFAOYSA-N Hydroxyurea Chemical compound NC(=O)NO VSNHCAURESNICA-UHFFFAOYSA-N 0.000 description 4
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 4
- 229960001330 hydroxycarbamide Drugs 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- 238000004448 titration Methods 0.000 description 4
- ZNBNBTIDJSKEAM-UHFFFAOYSA-N 4-[7-hydroxy-2-[5-[5-[6-hydroxy-6-(hydroxymethyl)-3,5-dimethyloxan-2-yl]-3-methyloxolan-2-yl]-5-methyloxolan-2-yl]-2,8-dimethyl-1,10-dioxaspiro[4.5]decan-9-yl]-2-methyl-3-propanoyloxypentanoic acid Chemical compound C1C(O)C(C)C(C(C)C(OC(=O)CC)C(C)C(O)=O)OC11OC(C)(C2OC(C)(CC2)C2C(CC(O2)C2C(CC(C)C(O)(CO)O2)C)C)CC1 ZNBNBTIDJSKEAM-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- AWUHRASXGNMZBQ-UHFFFAOYSA-N N',3,4-trihydroxybenzenecarboximidamide hydrochloride Chemical compound Cl.ON=C(N)C1=CC=C(O)C(O)=C1 AWUHRASXGNMZBQ-UHFFFAOYSA-N 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 229910000378 hydroxylammonium sulfate Inorganic materials 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- CRNPKFLXFKSNEW-UHFFFAOYSA-N 2,3,4-trihydroxybenzamide Chemical compound NC(=O)C1=CC=C(O)C(O)=C1O CRNPKFLXFKSNEW-UHFFFAOYSA-N 0.000 description 2
- HZNQSWJZTWOTKM-UHFFFAOYSA-N 2,3,4-trimethoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C(OC)=C1OC HZNQSWJZTWOTKM-UHFFFAOYSA-N 0.000 description 2
- KWQVATMODKRUEZ-UHFFFAOYSA-N 2-(3,4-dihydroxyphenyl)-n',2-dihydroxyethanimidamide Chemical compound ON=C(N)C(O)C1=CC=C(O)C(O)=C1 KWQVATMODKRUEZ-UHFFFAOYSA-N 0.000 description 2
- QITQDRKYQSXESA-UHFFFAOYSA-N 2-hydroxy-3,4,5-trimethoxybenzoic acid;hydrate Chemical compound O.COC1=CC(C(O)=O)=C(O)C(OC)=C1OC QITQDRKYQSXESA-UHFFFAOYSA-N 0.000 description 2
- IBGBGRVKPALMCQ-UHFFFAOYSA-N 3,4-dihydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1O IBGBGRVKPALMCQ-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical class NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 208000001382 Experimental Melanoma Diseases 0.000 description 2
- 208000028018 Lymphocytic leukaemia Diseases 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- KBKNXSNOQYLIRI-UHFFFAOYSA-N N',3,4,5-tetrahydroxybenzenecarboximidamide hydrochloride Chemical compound Cl.ON=C(N)C1=CC(O)=C(O)C(O)=C1 KBKNXSNOQYLIRI-UHFFFAOYSA-N 0.000 description 2
- 108091028664 Ribonucleotide Proteins 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000000908 ammonium hydroxide Substances 0.000 description 2
- 230000000118 anti-neoplastic effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000003610 charcoal Substances 0.000 description 2
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 208000003747 lymphoid leukemia Diseases 0.000 description 2
- NNICRUQPODTGRU-UHFFFAOYSA-N mandelonitrile Chemical compound N#CC(O)C1=CC=CC=C1 NNICRUQPODTGRU-UHFFFAOYSA-N 0.000 description 2
- 150000004682 monohydrates Chemical class 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- 238000006338 pulse radiolysis reaction Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 239000002336 ribonucleotide Substances 0.000 description 2
- 125000002652 ribonucleotide group Chemical group 0.000 description 2
- 235000010265 sodium sulphite Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical class O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- WCBPJVKVIMMEQC-UHFFFAOYSA-N 1,1-diphenyl-2-(2,4,6-trinitrophenyl)hydrazine Chemical group [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1NN(C=1C=CC=CC=1)C1=CC=CC=C1 WCBPJVKVIMMEQC-UHFFFAOYSA-N 0.000 description 1
- SINUYZQKBLIHOZ-UHFFFAOYSA-N 2,3,4,5,6-pentahydroxybenzamide Chemical compound NC(=O)C1=C(O)C(O)=C(O)C(O)=C1O SINUYZQKBLIHOZ-UHFFFAOYSA-N 0.000 description 1
- ZPJYPVNIXKKWAU-UHFFFAOYSA-N 2,3,4,5,6-pentamethoxybenzonitrile Chemical compound COC1=C(OC)C(OC)=C(C#N)C(OC)=C1OC ZPJYPVNIXKKWAU-UHFFFAOYSA-N 0.000 description 1
- ISSNOTRNQLZNJI-UHFFFAOYSA-N 2,3,4,5-tetrahydroxybenzamide Chemical compound NC(=O)C1=CC(O)=C(O)C(O)=C1O ISSNOTRNQLZNJI-UHFFFAOYSA-N 0.000 description 1
- WFRPMPXETUEEEL-UHFFFAOYSA-N 2,3,4,6-tetrahydroxybenzonitrile Chemical compound OC1=CC(O)=C(C#N)C(O)=C1O WFRPMPXETUEEEL-UHFFFAOYSA-N 0.000 description 1
- DCMWCEINHSWELV-UHFFFAOYSA-N 2,3,4-trihydroxybenzenecarboximidamide Chemical compound NC(=N)C1=CC=C(O)C(O)=C1O DCMWCEINHSWELV-UHFFFAOYSA-N 0.000 description 1
- NPFQPSKKBQGCKB-UHFFFAOYSA-N 2,3,5,6-tetrahydroxybenzonitrile Chemical compound OC1=CC(O)=C(O)C(C#N)=C1O NPFQPSKKBQGCKB-UHFFFAOYSA-N 0.000 description 1
- SRLTVIITBRPPCB-UHFFFAOYSA-N 2,3,5-trimethoxybenzoic acid Chemical compound COC1=CC(OC)=C(OC)C(C(O)=O)=C1 SRLTVIITBRPPCB-UHFFFAOYSA-N 0.000 description 1
- QQRXPYCOYVLNSY-UHFFFAOYSA-N 2-(2,3,4-trihydroxyphenyl)ethanimidamide Chemical compound NC(=N)CC1=CC=C(O)C(O)=C1O QQRXPYCOYVLNSY-UHFFFAOYSA-N 0.000 description 1
- PFBVIDZIRYKFQF-UHFFFAOYSA-N 2-(3,4-dihydroxyphenyl)-n',2-dihydroxyethanimidamide;hydrate Chemical compound O.ON=C(N)C(O)C1=CC=C(O)C(O)=C1 PFBVIDZIRYKFQF-UHFFFAOYSA-N 0.000 description 1
- OFQCQIGMURIECL-UHFFFAOYSA-N 2-[2-(diethylamino)ethyl]-2',6'-dimethylspiro[isoquinoline-4,4'-oxane]-1,3-dione;phosphoric acid Chemical compound OP(O)(O)=O.O=C1N(CCN(CC)CC)C(=O)C2=CC=CC=C2C21CC(C)OC(C)C2 OFQCQIGMURIECL-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- AUVPVHYYPCTFAV-UHFFFAOYSA-N 2-bromo-3,4,5-trimethoxybenzoic acid Chemical compound COC1=CC(C(O)=O)=C(Br)C(OC)=C1OC AUVPVHYYPCTFAV-UHFFFAOYSA-N 0.000 description 1
- MJZXQRQWAWCETQ-UHFFFAOYSA-N 2-hydroxy-3,4,5-trimethoxybenzoic acid Chemical compound COC1=CC(C(O)=O)=C(O)C(OC)=C1OC MJZXQRQWAWCETQ-UHFFFAOYSA-N 0.000 description 1
- DUZRNUWKVXKOID-UHFFFAOYSA-N 2-hydroxy-3,4,5-trimethoxybenzonitrile Chemical compound COC1=CC(C#N)=C(O)C(OC)=C1OC DUZRNUWKVXKOID-UHFFFAOYSA-N 0.000 description 1
- FSTPMFASNVISBU-UHFFFAOYSA-N 2-methoxybenzonitrile Chemical compound COC1=CC=CC=C1C#N FSTPMFASNVISBU-UHFFFAOYSA-N 0.000 description 1
- LSBDFXRDZJMBSC-UHFFFAOYSA-N 2-phenylacetamide Chemical class NC(=O)CC1=CC=CC=C1 LSBDFXRDZJMBSC-UHFFFAOYSA-N 0.000 description 1
- HMFSHIAGMDTXEV-UHFFFAOYSA-N 3,4,5-trihydroxybenzenecarboximidamide Chemical compound NC(=N)C1=CC(O)=C(O)C(O)=C1 HMFSHIAGMDTXEV-UHFFFAOYSA-N 0.000 description 1
- PCYGLFXKCBFGPC-UHFFFAOYSA-N 3,4-Dihydroxy hydroxymethyl benzene Natural products OCC1=CC=C(O)C(O)=C1 PCYGLFXKCBFGPC-UHFFFAOYSA-N 0.000 description 1
- YKILLPJZPZOZSV-UHFFFAOYSA-N 3,4-dihydroxybenzenecarboximidamide Chemical compound NC(=N)C1=CC=C(O)C(O)=C1 YKILLPJZPZOZSV-UHFFFAOYSA-N 0.000 description 1
- PLYYMFBDRBSPJZ-UHFFFAOYSA-N 3,5-dihydroxybenzamide Chemical compound NC(=O)C1=CC(O)=CC(O)=C1 PLYYMFBDRBSPJZ-UHFFFAOYSA-N 0.000 description 1
- SDEBYHVDMCQKNZ-UHFFFAOYSA-N 4-methoxy-6-piperazin-1-ylpyrimidine;hydrochloride Chemical compound Cl.C1=NC(OC)=CC(N2CCNCC2)=N1 SDEBYHVDMCQKNZ-UHFFFAOYSA-N 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 1
- NUXMQPDJTCPDTE-UHFFFAOYSA-N Cl.NC(=N)C1=CC(O)=C(O)C(O)=C1 Chemical compound Cl.NC(=N)C1=CC(O)=C(O)C(O)=C1 NUXMQPDJTCPDTE-UHFFFAOYSA-N 0.000 description 1
- DUZYVKZJSOLZLH-UHFFFAOYSA-N Cl.ON=C(N)C1=CC=CC(O)=C1O Chemical compound Cl.ON=C(N)C1=CC=CC(O)=C1O DUZYVKZJSOLZLH-UHFFFAOYSA-N 0.000 description 1
- 238000011765 DBA/2 mouse Methods 0.000 description 1
- YKRHSYLVLVOCRP-UHFFFAOYSA-N OC1=C(C(N)=NO)C=CC=C1O.OC1=C(C(=O)N)C=C(C(=C1)O)O Chemical compound OC1=C(C(N)=NO)C=CC=C1O.OC1=C(C(=O)N)C=C(C(=C1)O)O YKRHSYLVLVOCRP-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 230000000719 anti-leukaemic effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 210000003567 ascitic fluid Anatomy 0.000 description 1
- 229940054066 benzamide antipsychotics Drugs 0.000 description 1
- 150000003936 benzamides Chemical class 0.000 description 1
- 150000003937 benzamidines Chemical class 0.000 description 1
- VDEUYMSGMPQMIK-UHFFFAOYSA-N benzhydroxamic acid Chemical class ONC(=O)C1=CC=CC=C1 VDEUYMSGMPQMIK-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 1
- SFZULDYEOVSIKM-UHFFFAOYSA-N chembl321317 Chemical compound C1=CC(C(=N)NO)=CC=C1C1=CC=C(C=2C=CC(=CC=2)C(=N)NO)O1 SFZULDYEOVSIKM-UHFFFAOYSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 230000000332 continued effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- OMZSGWSJDCOLKM-UHFFFAOYSA-N copper(II) sulfide Chemical compound [S-2].[Cu+2] OMZSGWSJDCOLKM-UHFFFAOYSA-N 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 229940076286 cupric acetate Drugs 0.000 description 1
- FTDHDKPUHBLBTL-SHYZEUOFSA-K dCDP(3-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 FTDHDKPUHBLBTL-SHYZEUOFSA-K 0.000 description 1
- 230000017858 demethylation Effects 0.000 description 1
- 238000010520 demethylation reaction Methods 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- RCJVRSBWZCNNQT-UHFFFAOYSA-N dichloridooxygen Chemical compound ClOCl RCJVRSBWZCNNQT-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 238000004980 dosimetry Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- ANFZRGMDGDYNGA-UHFFFAOYSA-N ethyl acetate;propan-2-ol Chemical compound CC(C)O.CCOC(C)=O ANFZRGMDGDYNGA-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 239000005452 food preservative Substances 0.000 description 1
- 235000019249 food preservative Nutrition 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 239000003574 free electron Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 230000004132 lipogenesis Effects 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 230000000684 melanotic effect Effects 0.000 description 1
- SSDAYUCIUSMMRO-UHFFFAOYSA-N methyl 2-hydroxy-3,4,5-trimethoxybenzoate Chemical compound COC(=O)C1=CC(OC)=C(OC)C(OC)=C1O SSDAYUCIUSMMRO-UHFFFAOYSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- HBROZNQEVUILML-UHFFFAOYSA-N salicylhydroxamic acid Chemical class ONC(=O)C1=CC=CC=C1O HBROZNQEVUILML-UHFFFAOYSA-N 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- YUKQRDCYNOVPGJ-UHFFFAOYSA-N thioacetamide Chemical compound CC(N)=S YUKQRDCYNOVPGJ-UHFFFAOYSA-N 0.000 description 1
- DLFVBJFMPXGRIB-UHFFFAOYSA-N thioacetamide Natural products CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- BSOLAQMZTBVZLA-UHFFFAOYSA-N tyrosinyl radical Chemical compound OC(=O)C(N)CC1=CC=C([O])C=C1 BSOLAQMZTBVZLA-UHFFFAOYSA-N 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/32—Oximes
- C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/12—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
- C07C259/14—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/12—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
- C07C259/18—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to carbon atoms of six-membered aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Chemical And Physical Treatments For Wood And The Like (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Laminated Bodies (AREA)
- Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
- Fats And Perfumes (AREA)
- Detergent Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US497,370 | 1983-05-23 | ||
| US06/497,370 US4623659A (en) | 1983-05-23 | 1983-05-23 | Polyhydroxybenzoic acid derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1339221C true CA1339221C (en) | 1997-08-05 |
Family
ID=23976584
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000454910A Expired - Lifetime CA1339221C (en) | 1983-05-23 | 1984-05-23 | Polyhydroxybenzoic acid derivatives |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US4623659A (en, 2012) |
| EP (1) | EP0144396B1 (en, 2012) |
| JP (2) | JPS60501409A (en, 2012) |
| KR (1) | KR920004187B1 (en, 2012) |
| AT (1) | ATE59553T1 (en, 2012) |
| AU (1) | AU589111B2 (en, 2012) |
| CA (1) | CA1339221C (en, 2012) |
| DE (1) | DE3483822D1 (en, 2012) |
| DK (1) | DK13785D0 (en, 2012) |
| FI (1) | FI843681A7 (en, 2012) |
| IT (1) | IT1209548B (en, 2012) |
| NO (1) | NO843739L (en, 2012) |
| WO (1) | WO1984004676A1 (en, 2012) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2740133A (en) * | 1951-03-01 | 1956-04-03 | Seng Co | Detachable footboard for a bed |
| US4942253A (en) * | 1983-05-23 | 1990-07-17 | Riet Bartholomeus Van T | Polyhydroxybenzoic acid derivatives |
| US5183828A (en) * | 1983-05-23 | 1993-02-02 | Riet Bartholomeus Van T | Polyhydroxybenzoic acid derivatives |
| DE69232911T2 (de) | 1991-10-31 | 2003-11-13 | Inc. Molecules For Health | Verwendung eines polyhydroxybenzamids oder dessen Derivat zur Herstellung eines Medikaments für die Behandlung von viralen Infektionen |
| US5350770A (en) * | 1992-07-28 | 1994-09-27 | Elford Howard L | Therapeutic process for the treatment of septic shock |
| US6713517B1 (en) | 1996-03-08 | 2004-03-30 | Oxigene, Inc. | Use of aryl N-substituted carboxamides directly and as radio-and chemosensitizers for killing tumor and cancer cells and novel compounds for such use |
| US6028111A (en) * | 1996-03-08 | 2000-02-22 | Oxigene, Inc. | Compositions and use of benzamides and nicotinamides as anti-inflammatory agents |
| AU6575498A (en) * | 1997-03-20 | 1998-10-12 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Hydroxybenzoate metabolites and hydroxybenzoate analogues as protectors against oxidative stress and chemotherapeutic drug cytotoxicity, cardiotoxicity and extravasation tissue injury |
| US6924308B1 (en) * | 1997-07-30 | 2005-08-02 | Howard L. Elford | Therapeutic process for inhibiting NF-κB |
| US6516479B1 (en) * | 2000-06-02 | 2003-02-11 | Burke Mobility Products, Inc. | Foldable rehabilitation bed for accommodating an obese person |
| WO2004084631A1 (de) * | 2003-03-26 | 2004-10-07 | Bayer Cropscience Gmbh | Verwendung von hydroxyaromaten als safener |
| EP1744761A4 (en) * | 2004-04-28 | 2010-01-13 | Molecules For Health Inc | METHOD FOR THE TREATMENT OR PREVENTION OF RESTENOSIS AND OTHER PROLIFERATIVE VASCULAR DISORDER |
| EP2030615A3 (en) | 2007-08-13 | 2009-12-02 | ELFORD, Howard L. | Ribonucleotide reductase inhibitors for use in the treatment or prevention of neuroinflammatory or autoimmune diseases |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB358279A (en) * | 1930-10-07 | 1931-10-08 | Ig Farbenindustrie Ag | Process for inhibiting the development of micro organisms |
| US2849480A (en) | 1956-10-05 | 1958-08-26 | Kreuchunas Algird | Process for the preparation of 2, 3, 6-trihydroxybenzoic acid and derivatives |
| US3629443A (en) | 1967-11-29 | 1971-12-21 | Orsymonde | Therapeutic composition containing a mandelamidine derivative |
| GB1243186A (en) * | 1967-11-29 | 1971-08-18 | Orsymonde | Improvements in or relating to mandelamidine derivatives |
| US4263322A (en) * | 1979-03-01 | 1981-04-21 | Riet Bartholomeus Van T | Hydroxy benzohydroxamic acids and benzamides |
| US4236322A (en) | 1979-03-15 | 1980-12-02 | Hastings Allen M | Apparatus for and method of drying items by open air and solar energy |
-
1983
- 1983-05-23 US US06/497,370 patent/US4623659A/en not_active Expired - Lifetime
-
1984
- 1984-05-21 DE DE8484902270T patent/DE3483822D1/de not_active Expired - Lifetime
- 1984-05-21 WO PCT/US1984/000755 patent/WO1984004676A1/en active IP Right Grant
- 1984-05-21 EP EP84902270A patent/EP0144396B1/en not_active Expired - Lifetime
- 1984-05-21 AU AU30130/84A patent/AU589111B2/en not_active Expired
- 1984-05-21 AT AT84902270T patent/ATE59553T1/de not_active IP Right Cessation
- 1984-05-21 JP JP59502128A patent/JPS60501409A/ja active Granted
- 1984-05-23 IT IT8421068A patent/IT1209548B/it active
- 1984-05-23 CA CA000454910A patent/CA1339221C/en not_active Expired - Lifetime
- 1984-05-23 KR KR1019840002882A patent/KR920004187B1/ko not_active Expired
- 1984-09-19 NO NO843739A patent/NO843739L/no unknown
- 1984-09-20 FI FI843681A patent/FI843681A7/fi not_active Application Discontinuation
-
1985
- 1985-01-11 DK DK13785A patent/DK13785D0/da not_active Application Discontinuation
-
1992
- 1992-02-26 JP JP4039794A patent/JPH0578299A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IT1209548B (it) | 1989-08-30 |
| US4623659A (en) | 1986-11-18 |
| JPS60501409A (ja) | 1985-08-29 |
| JPH0578299A (ja) | 1993-03-30 |
| FI843681A7 (fi) | 1984-11-24 |
| JPH051780B2 (en, 2012) | 1993-01-11 |
| DK13785A (da) | 1985-01-11 |
| KR850001160A (ko) | 1985-03-16 |
| AU589111B2 (en) | 1989-10-05 |
| DE3483822D1 (de) | 1991-02-07 |
| IT8421068A0 (it) | 1984-05-23 |
| NO843739L (no) | 1984-12-06 |
| FI843681A0 (fi) | 1984-09-20 |
| AU3013084A (en) | 1984-12-18 |
| KR920004187B1 (ko) | 1992-05-30 |
| EP0144396A4 (en) | 1986-08-21 |
| EP0144396B1 (en) | 1991-01-02 |
| DK13785D0 (da) | 1985-01-11 |
| EP0144396A1 (en) | 1985-06-19 |
| WO1984004676A1 (en) | 1984-12-06 |
| ATE59553T1 (de) | 1991-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1339221C (en) | Polyhydroxybenzoic acid derivatives | |
| DE4326465A1 (de) | Aminosäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung | |
| JP2002510320A (ja) | 新規な一酸化窒素放出アミジンおよびエナミン誘導ジアゼニウムジオレート、組成物およびそれらの用途、ならびにその製造方法 | |
| US4263322A (en) | Hydroxy benzohydroxamic acids and benzamides | |
| JPH024761A (ja) | アリールヒドラゾン | |
| CA1300619C (en) | 1-(4-hydroxy-3,5-di-tert.-butylbenzoyl)homopiperazine, various derivatives thereof, processes for the preparation of these compounds, medicaments containing them, and their use | |
| US4448730A (en) | Hydroxybenzohydroxamic acids, benzamides and esters and related compounds as ribonucleotide reductase inhibitors | |
| US4394389A (en) | Hydroxybenzohydroxamic acids, benzamides and esters as ribonucleotide reductase inhibitors | |
| Baiocchi et al. | Studies on methylglyoxal bis (guanylhydrazone) 1 analogs. II. Structural variations on methylglyoxal bis (guanylhydrazone) 2 | |
| HU189608B (en) | Process for producing pyridazine derivatives | |
| US5183828A (en) | Polyhydroxybenzoic acid derivatives | |
| CA1196656A (en) | 4-amino-hepta-5,6-dienoic acid | |
| US4942253A (en) | Polyhydroxybenzoic acid derivatives | |
| SU1318158A3 (ru) | Способ получени производных 4-замещенного-1,3,4,5-тетрагидро-2 @ -1,4-бензодиазепин-2-она | |
| KR860001888B1 (ko) | 디하이드록시 벤조산 유도체의 제조방법 | |
| RU2081108C1 (ru) | Аддитивные соли кислот с основанием и фармацевтическая композиция, обладающая противоопухолевой активностью | |
| US5438057A (en) | Pharmaceutical compositions | |
| EP0041827B1 (en) | A n-(benzylidene) aminomethyl-cyclohexane-carboxylic acid | |
| O'Brien | Complexes of D-Cycloserine and Related Amino Acids with Antibiotic Properties | |
| US3953461A (en) | Amino derivatives of thiazolo[5,4-b]pyridine-6-carboxylic acids and esters | |
| US4361572A (en) | Tetrahydronicotinamide derivative, pharmaceutical compositions and use | |
| US4892939A (en) | Oligopeptidyl-5-fluorouridine compounds and process for preparing the same | |
| KR850001880B1 (ko) | 트란스-4-[n-(3', 4'-메틸렌디옥시벤질리덴)아미노메틸] 사이클로헥산-1-카복실산 및 이의 유도체의 제조방법 | |
| US4329355A (en) | Mesoionic antitumor compositions and methods for using the same in the treatment of cancer | |
| US4051251A (en) | Novel anti-hypertensive compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |
Effective date: 20140805 |